Clinical trials are fundamental to the development of new practices, medicines and devices to treat and prevent illness.
Alfred Research Alliance has significant capabilities in the conduct of Phase I to Phase IV clinical trials, giving us the depth and breadth of expertise to translate our discoveries into new interventions on-site.
Baker Heart and Diabetes Institute
Research projects at the Baker Institute have the potential to change the face of diabetes and heart disease prevention and management. Often, this groundbreaking research would not be possible without volunteers participating in clinical trials.
Clinical research trials at the Baker Institute may involve new drugs, devices or lifestyle strategies to help manage pre-existing medical conditions, while others may look at preventative measures to reduce the risk of disease.
Nucleus Network is Australia’s leading Clinical Research Organisation (CRO). Their 80-bed facility and services assist a global sponsor base of Biotechnology and Pharmaceutical companies. Nucleus specialises in the conduct of First-in-Human, Phase I Clinical Trials and other complex Clinical Trials including Biosimilars.
Monash School of Public Health and Preventive Medicine
The Monash School of Public Health and Preventive Medicine (SPHPM) has substantial expertise and experience in the design, conduct and analysis of Phase 2-4 clinical trials. It is the lead centre for ASPREE, Australia’s largest clinical trial.
SPHPM establishes large investigator-initiated trials and co-ordinates industry-funded multicentre studies including:
- competitive-grant and industry-sponsored trials
- local and international trials
- hospital-based and community-based trials
- pharmacokinetic and pharmacodynamic studies
- safety and efficacy studies.
The Australian and New Zealand Intensive Care Research Centre
The Australian and New Zealand Intensive Care Research Centre (ANZIC-RC) is an intensive care clinical research methods centre and is part of the Monash School of Public Health and Preventive Medicine (SPHPM).
The ANZIC-RC assists with the design, funding and conduct of clinical trials. Advice is available from experienced intensive care unit researchers, data management/bio-statistical consultants, project managers, epidemiologists and health economists.
The Centre coordinates and conducts comprehensive research programs including observational studies; feasibility projects; and large multi-centred, interventional, randomised controlled trials. It has the ability to support small, medium and large clinical trials.
The Australian and New Zealand College of Anaesthetists Trials Group
The Australian and New Zealand College of Anaesthetists (ANZCA) Trials Group aims to improve the evidence base of anaesthesia, perioperative and pain medicine by supporting multicentre research, and collaborating with other trials groups.
Members of the ANZCA Trials Group are highly skilled in the theory and practice of research methodology and have a record of success in the coordination, conduct and management large, multicentre, randomised, controlled trials.
The ANZCA Trials Group is co-located at Monash SPHPM and the Australian and New Zealand College of Anaesthetists.
360biolabs is Australia’s most comprehensive speciality laboratory services organisation for therapeutic, vaccine and diagnostics development.
They develop and conduct pharmacokinetic (PK) and pharmacodynamic (PD) assays across a wide variety of therapeutic areas and provide extensive support services to ensure the success of preclinical studies and clinical trials.